share_log

4: Statement of changes in beneficial ownership of securities-Director XU CHERYL

4: Statement of changes in beneficial ownership of securities-Director XU CHERYL

4：持股變動聲明-董事 XU CHERYL
美股sec公告 ·  05/22 08:25
牛牛AI助理已提取核心訊息
Cheryl Xu, associated with 60 Degrees Pharmaceuticals, completed a purchase of 2,000 shares of common stock on May 16, 2024. The transaction was executed at a price of $0.223 per share, resulting in a total investment of $446. Following the action, Xu's direct holdings in the company increased to 228,934 shares. The transaction is classified as an exercise or conversion of derivative security, according to the transaction code description.
Cheryl Xu, associated with 60 Degrees Pharmaceuticals, completed a purchase of 2,000 shares of common stock on May 16, 2024. The transaction was executed at a price of $0.223 per share, resulting in a total investment of $446. Following the action, Xu's direct holdings in the company increased to 228,934 shares. The transaction is classified as an exercise or conversion of derivative security, according to the transaction code description.
與60度製藥有聯繫的謝麗爾·徐於2024年5月16日完成了對2,000股普通股的收購。該交易以每股0.223美元的價格執行，總投資額爲446美元。行動後，徐在公司的直接持股量增加到228,934股。根據交易代碼的描述，該交易被歸類爲衍生證券的行使或轉換。
與60度製藥有聯繫的謝麗爾·徐於2024年5月16日完成了對2,000股普通股的收購。該交易以每股0.223美元的價格執行，總投資額爲446美元。行動後，徐在公司的直接持股量增加到228,934股。根據交易代碼的描述，該交易被歸類爲衍生證券的行使或轉換。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。